Researchers have discovered that an enzyme can serve as an ideal target for developing new therapeutics against Lyme disease, and most likely other tick-borne diseases as well.

Daniel Capelluto and his research team have discovered the mechanism by which the bacterial pathogen Shigella flexneri ... an ...